Home > PJ (current issue)> Articles

PJ Online homeThe Pharmaceutical Journal
Vol 274 No 7334 p121-122
29 January 2005

This article
Reprint   Photocopy

PDF 75K, Acrobat Reader

Articles

Proper measurement of blood pressure would save lives and money

In this article, Bob Michell discusses why pharmacists are well placed to measure blood pressure and the best way to do it


Professor Michell graduated as a veterinary surgeon but, following postdoctoral experience in various American medical institutes, has pursued a career in caparative medicine in which he holds a personal chair at the University of London (St Bartholomew’s Hospital)
e-mail b.michell@qmul.ac.uk

Measuring blood pressure

A single reading is practically useless

Doctors are not good at measuring blood pressure, even though it is important. Nurses are generally better; they have more patience — they repeat readings whereas doctors regard themselves as too busy. Yet single readings are practically useless and hypertension, with its consequences, is a huge drain on NHS budgets. The procedure, sanctified by antiquity, is more like a religious ceremony than a scientifically validated clinical technique. This is bizarre considering the ease and sophistication with which BP can be measured, even throughout 24 hours, given the will and the equipment to do it properly. BP measurement is set to change — hopefully to catch up with modern standards of reproducibility (precision) — as tighter laws on toxic hazards may lead to the elimination of the venerable mercury sphygmomanometer, second only to the stethoscope in the doctor’s traditional regalia.

Blood pressure is the oldest surviving instrumented medical measurement, predating the clinical thermometer, so it is time that it was done properly. The emergence of pharmacists as front-line troops in the battle to spot and control hypertension early, before the damage begins silently and asymptomatically, is appropriate since they are well placed to achieve progress in three key areas: accurate measurement, astute evaluation of side effects and maximisation of compliance. All of these are currently achieved only haphazardly, resulting in great personal cost to patients and financial cost to the health budget.

Inadequate measurements cost lives

There used to be a war-time poster campaign “careless talk costs lives”; there should be a similar campaign concerning careless blood pressure measurement. It remains true that only a minority of people with hypertension are correctly diagnosed and of these, only a minority are properly treated. Most, for example, require more than one medicine to regain the normal range.

Inadequate measurement creates three unnecessary sources of hypertensive damage or cost: premature use of medication among those who are not hypertensive, lack of medication among those who are, and flawed evaluation of response to therapy, leading to misguided decisions on changes of medication. It is hard enough to control blood pressure over decades of patients’ lives, often in the early stages with drugs that cause more discomfort than the underlying condition. It is even harder if the beacon measurement routinely remains a haphazard shot in the dark. There is a clear opportunity for pharmacists not just to relieve doctors of unnecessary work, but to set an example by doing properly the measurement which is so poorly performed in most GP surgeries.1,2

What do we need to measure?

If we ask “what is normal blood pressure?” or “what matters about abnormal blood pressure?” the answers remain surprisingly mysterious. Of course, physiologically, we are taught arterial pressure regulation as a great example of negative feedback ensuring homeostatic constancy at the “set-point”, like body temperature. If arterial pressure falls, cardiac output or peripheral resistance are increased to restore it to “normal”, just like thermostats and central heating.

If Reverend Stephen Hales time-warped from the 18th century into a physiology class he would be bewildered by this idea. If his famous pioneering measurements from horses, and especially from dogs, are converted from feet of blood into modern measurements, they are remarkably authentic. “If it is so perfectly regulated,” he might have asked “why is it so remarkably variable?” Which it is, as he observed and as we now know, not only hour by hour, not just because of distractions, but even minute by minute. Perhaps the most mysterious aspect of blood pressure is the fact that something so variable, so carelessly measured, remains characteristic of individual patients; if a human cohort is followed as it matures over the decades there is “tracking” of blood pressure, ie, the rank order of the individuals remains similar; similar evidence exists for dogs, although over much shorter timespans.

Since blood pressure is inherently variable, at least five readings should be averaged, excluding outliers. The first reading probably serves to seat the cuff so it should be discarded. It is also important that the cuff is approximately level with the heart, is the correct size in relation to the circumference of the arm and that the measuring device has been properly validated, calibrated and maintained. Ideally, time of day should be standardised for an individual, because of the diurnal rhythm of BP, and the patient must be given time (ideally five minutes) to settle before measurements begin; even slight anxiety elevates BP (the white coat effect). Such precautions, routinely applied to blood pressure measurement in dogs, yield much more reproducible readings in humans than those obtained by the usual clinical routine.1–3 Sadly, the current recommendation of the British Hypertension Society is still to rely on merely two readings;4 you might as well define the depth of the Thames at Westminster with two consecutive readings at unspecified times. The guidelines do, however, acknowledge the unreliability of the first reading (still the only reading taken by many GPs).

Recently, with the growth in home measurement and ambulatory blood pressure measurement, the concept of “masked” hypertension has emerged.5 This is the opposite of white coat hypertension (where pressure is elevated in the clinic). Masked hypertension is particularly damaging because pressure appears to be normal in the clinic but is actually higher elsewhere, hence by escaping detection masked hypertension makes patients more vulnerable to consequential damage. A key predisposing factor in masked hypertension is simply taking an insufficient number of measurements in the clinic.6 In each cardiac cycle, arterial pressure reaches a peak (systolic) and a trough (diastolic); these, together with mean arterial pressure are the three usual measurements. Mean is not simply an average of the other two but reflects the change in pressure over time during the cycle. Since systole is fast whereas diastole is slow, it lies nearer to diastolic pressure. When heart rate increases, diastole shortens so mean arterial pressure increases. With increased BP, there is controversy as to which does more harm, systolic or diastolic pressure, and it may well be the difference between them, the pulse pressure, which matters most.

Hypertension in veterinary medicine

With the Government’s wish to see pharmacists routinely dispensing veterinary prescriptions, pharmacies will soon be dealing with hypertensive cats and dogs, as well as humans. Essential hypertension, ie, primary hypertension (no other apparent cause), predominates in humans but in cats and dogs hypertension is usually secondary to underlying disease, especially renal disease in cats, diabetes and Cushing’s disease in dogs; it also occurs in canine chronic renal failure but much less often than in humans. In cats the clinical presentation is often blindness due to retinal haemorrhage.

For measurements in dogs, the best equipment, because it has been properly validated in published peer-reviewed papers, is the “DINAMAP” oscillometric monitor, using the correct sized cuff on the tail base.7 It is much harder to use in cats, with the cuff needing to be applied ahead of connection to the machine, and plenty of time to settle — even then some cats will not give a reading. Hence, although oscillometric techniques display the three routine pressures and heart rate, many prefer the Doppler technique for cats. Even though this only gives systolic pressure, it provides clear indications of moderate or severe hypertension. These indirect techniques avoid arterial puncture which is quite unsuitable for conscious animals, although direct measurement is preferable for anaesthetised animals because it is more accurate, ie, reads closer to the true (intra-aortic) value. In conscious animals accuracy matters less than precision, so that departures from the normal range for that technique are dependably detected.

With dogs, any definition of hypertension has to take account of the considerable breed differences in normal pressure; the normal range for Labradors for example, is different from that for “sight hounds”, eg, deerhounds, which have far higher pressures. Why they have these higher pressures, especially the relevant genetic determinants, and why they are apparently unharmed is an intriguing focus of research; if they really are unharmed they are not truly hypertensive.

Blood pressure rises with age but this probably results from excessive dietary sodium intake. This should be a matter for serious concern since the majority of salt intake is passive rather than discretionary. The slope of the rise for any individual could well predestine whether he or she will need antihypertensive medication during later decades. Blood, of course, has many pressures — venous, capillary, arterial — and even with arterial, it differs according to the site of measurement. In peripheral arteries, compared with the aorta, it is augmented by interaction with pressure waves reflected from branch points in the arterial tree. Some tall, fit, athletic teenagers have abnormally high pressures, measured in their arms, but their central (aortic) pressures are normal so they are unharmed. In contrast, people with diabetes are at risk even with normal arterial pressures. Diabetes is the biggest single cause of the need for renal transplants: diabetic nephropathy is substantially a consequence of hypertensive renal damage, even at normal blood pressures. Afferent arterioles, which supply the glomeruli, are abnormally relaxed in diabetics. Normal pressure in the glomeruli (although higher than other capillaries) is well below arterial pressure, because pressure falls across the resistance offered by the afferent arterioles. If they are too slack, that protection is lost; glomeruli experience abnormally high pressures even when arterial pressure remains normal. People with diabetes therefore need to keep their blood pressure at the lower end of the normal range.

Since populations show a normal distribution of BP (although not quite bell shaped), there are inevitably individuals at either extreme. It does not necessarily harm them, any more than being seven feet tall. Hence hypertension, meaning a potentially damaging elevation of BP, is not defined statistically (eg, two standard deviations from average) but by the threshold above which the risk of adverse effects increases, eg, damage to retinal, coronary, renal and cerebral blood vessels (hence strokes). Normal human BP is routinely regarded as 140/90 (systolic/diastolic) but there is recent evidence that even below this, higher pressures are less healthy.

We have much to learn and the bedrock of progress will be proper measurement, with all the patience which our patients deserve. No other human disease comes close to the combined costs of treating hypertension and the consequential costs of failing to do so adequately.


References

1. Michell AR. Routine blood pressure measurement: application of the standard canine technique in a human. Blood Pressure Monitoring 1996;1:385–7.

2. Michell AR. Blood pressure measurement: single measurements would not withstand 21st century peer review. BMJ 2001;323:805–6

3. Michell AR. Blood pressure measurement and hypertension in dogs. In Practice 2000;22:274–5.

4. Williams B, Poulter NR, Brown MJ, Davis M, McInnes GT, Potter JF et al. Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV. Journal of Human Hypertension 2004;18:139–85.

5. Palatini P. Masked hypertension: how can the condition be detected? Blood Pressure Measurement 2004;9:297–9.

6. Mallion JM, Genes N, Vaur L, Clerson P, Vaisse B, Bobrie G et al. Detection of masked hypertension by home blood pressure measurement; is the number of measurements an important issue? Blood Pressure Measurement 2004;9:301–6.

7. Bodey AR, Michell AR. Reproducibility and variability of indirect (oscillometric) blood pressure measurements in dogs: longitudinal studies. Research in Veterinary Science 1996;63:15–22.

Back to Top


©The Pharmaceutical Journal